Log In
Print this Print this

Recombinant hirudin

  Manage Alerts
Collapse Summary General Information
Company Chongqing Kerun Biopharmaceutical R&D Co. Ltd.
DescriptionDirect thrombin inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentDiscovery
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat and prevent embolism
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today